Abstract:It has been argued that the evidence for the unreliability of psychiatric diagnosis is based on studies that have been poorly designed and that the issue is still an open one. It is clear, however, that the routine diagnoses used in psychiatry are quite inadequate as a basis for furthering our knowledge of mental illness and that they must give way to some more public and quantitative instrument. This does not mean that the observations of psychiatrists as brilliant as Kraepelin cannot be used for the development of such an instrument, quite the contrary. It does not mean that the clinical interview does not serve other very valuable functions, nor is it implied that the Runwell Symptom-Sign Inventory is fully adequate as a quantitative instrument. It is hoped, however, that it does illustrate some of the problems at issue, and that the distinction between symptoms and signs on the one hand and personality traits on the other will aid progress in this field. The results obtained with this Inventory for 80 psychotic and 140 neurotic women have been described. The overall agreement with the clinical diagnosis was 63 per cent. in the main sample and 55 per cent. in a small additional sample. In 12 and 17 per cent. respectively, the diagnosis on the RSSI was uncertain and in 25 and 27 per cent. respectively, the RSSI diagnosis was in disagreement with the clinical diagnosis. As would be expected, diagnosis among neurotics was more difficult than among psychotics or between neurotics and psychotics. The Inventory tended to over-diagnose the depressive group and to miss Hysterics; but it was thought that this might be a benign error. Frequency distributions in the various groups were used to distinguish between frequency of occurrence of a symptom in a particular group and its differential power as between groups. Utilizing this distinction, a description was given of the characteristics of five groups of women—Paranoids, Psychotic Depressives, Hysterics, Anxiety States and Neurotic Depressives as derived from responses on the Symptom-Sign Inventory. Characteristics which differentiated between any one neurotic group and at least three of the other four groups were very few. Psychotics were much better differentiated.

Resorcylic Acid Lactone L-783,277 Inhibits the Growth of the Human Adrenal Cancer Cell Line H295R in Vitro

Cardioprotection by Polysaccharide Sulfate Against Ischemia/reperfusion Injury in Isolated Rat Hearts.

Puerarin Protects against Myocardial Ischemia/Reperfusion Injury by Inhibiting Ferroptosis

Recent advances in the structure-activity relationships of substituted corticosteroids.

Pachymic acid (PA) inhibits ferroptosis of cardiomyocytes via activation of the AMPK in mice with ischemia/reperfusion‐induced myocardial injury

PIM3 regulates myocardial ischemia/reperfusion injury via ferroptosis

Activation of PPAR-α attenuates myocardial ischemia/reperfusion injury by inhibiting ferroptosis and mitochondrial injury via upregulating 14-3-3η

Targeting Ferroptosis by Polydopamine Nanoparticles Protects Heart against Ischemia/Reperfusion Injury

The Protective Effect of Cyanidin-3-Glucoside on Myocardial Ischemia-Reperfusion Injury through Ferroptosis

Pentoxifylline protects against cerebral ischaemia-reperfusion injury through ferroptosis regulation via the Nrf2/SLC7A11/GPX4 signalling pathway

Activation of NRF2/FPN1 pathway attenuates myocardial ischemia-reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosis

Pterostilbene attenuates heart failure by inhibiting myocardial ferroptosis through SIRT1/GSK-3β/GPX4 signaling pathway

Paeonol improves angiotensin II-induced cardiac hypertrophy by suppressing ferroptosis

PCSK9 inhibitor protects against myocardial ischemia-reperfusion injury via inhibiting LRP8/GPX4-mediated ferroptosis

Procyanidins Alleviated Cerebral Ischemia/Reperfusion Injury by Inhibiting Ferroptosis via the Nrf2/HO-1 Signaling Pathway

Ferrostatin-1 suppresses cardiomyocyte ferroptosis after myocardial infarction by activating Nrf2 signaling

USP22 Protects Against Myocardial Ischemia–Reperfusion Injury via the SIRT1-p53/SLC7A11–Dependent Inhibition of Ferroptosis–Induced Cardiomyocyte Death

Mild therapeutic hypothermic protection activates the PI3K/AKT signaling pathway to inhibit TRPM7 and suppress ferroptosis induced by myocardial ischemia‐reperfusion injury

A quantification of diagnostic differentiae.

Protective Effect of Compound Tongluo Decoction on Brain Vascular Endothelial Cells after Ischemia‐Reperfusion by Inhibition of Ferroptosis Through Regulating Nrf2/ARE/SLC7A11 Signaling Pathway

Icariin inhibits hypoxia/reoxygenation‐induced ferroptosis of cardiomyocytes via regulation of the Nrf2/HO‐1 signaling pathway